LEP and chronic obstructive pulmonary disease: Meanwhile, the obese COPD phenotype shows a distinct metabolic–inflammatory pattern of elevated leptin levels, low-grade systemic inflammation, and reduced physical activity factors that collectively contribute to metabolic syndrome and elevated cardiovascular risk.